Philips CPAP Injury Lawsuits To Be Selected For Potential Bellwether Trials in October 2024
Under a new schedule issued last week, it is likely that Philips CPAP injury lawsuit bellwether trials will not begin until late 2025, at the earliest.
Under a new schedule issued last week, it is likely that Philips CPAP injury lawsuit bellwether trials will not begin until late 2025, at the earliest.
Recalled LifeGlobal culture media allegedly damaged embryos during in vitro fertilization (IVF), according to lawsuit filed against CooperSurgical, which indicates the manufacturer failed to adequately design and test the device.
As the aviation industry grapples with an increased demand, new FAA rules will require additional time between shifts to address serious safety risks posed by air traffic controller fatigue.
Catholic clergy sex abuse claims claims set to go before juries could wipe out available funds for the Diocese of Sacramento, leading it to seek protection through bankruptcy
Further improvements to medical device quality, surveillance and the medical device recall program are planned by the FDA throughout 2024.
Lawyers indicate that that questions about whether the GLP-1 RA medication label warnings adequately disclose the risk of gastroparesis and other severe injuries will play a large role in the growing litigation.
Xarelto and Eliquis have already been linked to increased bleeding risks, which the new study says could be made worse by some hypertension drugs commonly prescribed as an atrial fibrillation combination therapy
The verdict marks the first talcum powder ovarian cancer lawsuit to be completed since Johnson & Johnson attempted to force the settlement of all claims through the U.S. Bankruptcy system, delaying the litigation for two years.
Owners are being instructed to enable the automatic door-locking feature to prevent the Toyota Prius doors from unexpectedly opening until repair parts become available.
The Court determined that there were deficiencies in the experts determination that there is a causal link between Paraquat and Parkinson's disease, rendering the testimony insufficiently reliable to allow a jury to consider it at trial.